Fund Universe

Merck & Co., Inc. (MRK)

CIK 0000310158 · holdings for 2026Q2 (change vs 2026Q1) · in signal universe
Quality Q
0.821
AUM ($M)
526
Positions
13
Turnover
0.16
Top-10 wt
100%
Herfindahl
0.257
History (qtrs)
6
Excess Return

AI Eval Run AI Eval

No AI Eval requested yet for this fund.
Quarter
Activity this period
Security type

Holdings · 17 positions · portfolio value $526M

TickerNameActivitySecurity Type WeightΔ Weight Value ($M)SharesΔ Shares Qtrs HeldExcess Return
PSNL funds › PERSONALIS INC HOLD 35.8% +10.1% 188.2 14,044,943 +0 0
MRNA funds › MODERNA INC HOLD 30.7% -2.8% 161.6 2,308,190 +0 0
KYMR funds › KYMERA THERAPEUTICS INC HOLD 16.8% -1.6% 88.5 772,165 +0 0
AKTS funds › AKTIS ONCOLOGY INC HOLD 5.8% +1.0% 30.7 952,844 +0 0
EIKN funds › EIKON THERAPEUTICS INC HOLD 4.1% -0.9% 21.7 1,666,666 +0 0
TRDA funds › ENTRADA THERAPEUTICS INC NEW 2.4% +2.4% 12.8 1,739,768 +1,739,768 0
STRO funds › SUTRO BIOPHARMA INC NEW 1.7% +1.7% 9.0 272,351 +272,351 0
ALEC funds › ALECTOR INC HOLD 1.4% -0.8% 7.1 3,545,719 +0 0
CUSIP:29970R303 funds › EVAXION BIOTECH A/S NEW 0.7% +0.7% 3.8 1,214,126 +1,214,126 0
VRDN funds › VIRIDIAN THERAPEUTICS INC HOLD 0.3% -0.2% 1.7 93,414 +0 0
XLO funds › XILIO THERAPEUTICS INC HOLD 0.2% -0.1% 1.0 105,982 +0 0
HURA funds › TUHURA BIOSCIENCES INC HOLD 0.0% -0.0% 0.0 19,445 +0 0
NEUP funds › NEUPHORIA THERAPEUTICS INC HOLD 0.0% -0.0% 0.0 10,027 +0 0
CUSIP:869367102 funds › SUTRO BIOPHARMA INC EXIT 0.0% -1.9% 0.0 0 -272,351 0
CUSIP:14216R101 funds › CARISMA THERAPEUTICS INC EXIT 0.0% -0.0% 0.0 0 -1,473,240 0
CUSIP:29384C908 funds › ENTRADA THERAPEUTICS INC EXIT 0.0% -6.3% 0.0 0 -1,739,768 0
CUSIP:29970R204 funds › EVAXION BIOTECH A/S EXIT 0.0% -1.3% 0.0 0 -1,214,126 0

Point-in-time history

Each row is this fund as of that period, not as of today — what the scoring for that quarter actually saw.
PeriodAUM ($M)Positions TurnoverTop-10 wtHerfindahl Quality Q Skill Universe
2026Q2 526 13 0.16 100% 0.257 0.821 in
2026Q1 349 14 0.20 100% 0.222 0.722 in
2025Q4 276 12 0.05 100% 0.277 0.865 in
2025Q3 228 13 0.07 100% 0.271 0.831 in
2025Q2 216 13 0.16 100% 0.298 0.732 entered
2025Q1 164 12 0.00 100% 0.276 0.000 out
Long US-equity 13F disclosures only · up to 45-day reporting lag · sells = reduce/avoid, not short. JSON: /api/signals · /api/funds · /api/status